YERXA BENJAMIN R 4

What Happened
Benjamin R. Yerxa, President and a director of Opus Genetics (IRD), reported a sale of 7,429 shares on 2026-07-23 at $2.97 per share, generating $22,064. This was a sale (code S) and not a buy—such sales are often routine rather than a directional signal.

Key Details

• Transaction date and price: 2026-07-23 — 7,429 shares @ $2.97 each (total ~$22,064).
• Shares owned after transaction: Not specified in the summary provided (not reported here).
• Footnote: The shares were sold automatically to satisfy tax withholding obligations arising from the vesting/settlement of restricted stock units (RSUs). This was an automatic, non‑discretionary sale.
• Filing timeliness: Form 4 filed 2026-07-27; this filing appears timely (within the standard two business‑day reporting window).

Context
This transaction reflects an automatic tax-withholding sale related to RSU vesting, per the filer’s footnote, not an active trading decision. For retail investors, purchases by insiders can be more informative about confidence in the company; routine withholding sales are common and typically do not indicate a change in insider sentiment.